𝔖 Bobbio Scriptorium

✦ LIBER ✦

Discovery Labs announces US commercial launch of Surfaxin (lucinactant)

Book ID: 122260226
Publisher: Elsevier Science
Year: 2014
Weight: 53 KB
Volume: 2014
Category: Article
ISSN: 1351-4210
DOI: 10.1016/S1351-4210(14)70014-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery Labs announces FDA approval of

Discovery Labs announces FDA approval of Surfaxin (lucinactant) for prevention of respiratory distress syndrome

📂 Article 📅 2012 🏛 Elsevier Science ⚖ 45 KB